Arcellx, Inc.ACLXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank30
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-2.83%
↓ 115% vs avg
Percentile
P30
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
19.24%
Historical baseline
PeriodValue
Q4 2025-2.83%
Q3 2025-6.75%
Q2 2025-25.93%
Q1 202513.78%
Q4 202413.98%
Q3 2024-4.35%
Q2 202426.72%
Q1 202412.28%
Q4 2023-34.29%
Q3 202354.65%
Q2 2023-13.98%
Q1 202326.94%
Q4 2022-68.92%
Q3 2022278.00%
Q2 202222.30%
Q1 202234.81%
Q4 20218.67%
Q3 2021-2.52%
Q2 202148.37%
Q1 202123.10%
Q4 20200.00%